Pharmaceutical manufacturers of Mannitol

Pfanstiehl is globally recognized as a leader in manufacturing cGMP high-purity, low-endotoxin, low-metal injectable-grade excipients and biopharmaceutical components for various applications in bioprocessing, formulation, and specialty areas. Additionally, Pfanstiehl operates as a prominent contract development and manufacturing organization (CDMO), specializing in the isolation, purification, custom synthesis, and scale-up development of small molecule Active Pharmaceutical Ingredients (APIs) ranging from gram to multi-ton commercial quantities. While many ingredient manufacturers or resellers cater to various industries like food, cosmetics, agriculture, and nutritional supplements, providing only a limited range of “pharma-grade” ingredients, Pfanstiehl’s exclusive focus lies in Biopharma applications, demonstrating a dedicated commitment to this specific sector

ROQUETTE is dedicated to providing the finest from natural sources. It stands as a worldwide frontrunner in plant-derived components, an innovator in plant-derived proteins, and a top supplier of medical excipients. By working alongside its clients and associates, the organization tackles present and future societal obstacles by harnessing the capabilities of nature to present superior ingredients for the food, nutrition, and health sectors. These components satisfy distinct and vital requirements, promote healthier ways of living, and are essential elements of life-preserving medications.

Rochem International, Inc. has been a prominent distributor of pharmaceutical, food, nutritional, and animal health ingredients since its establishment in 1994. It procures top-notch ingredients produced in China. With its headquarters in Hauppauge, New York, Rochem operates 16 global offices to meet its clients' requirements. The company's activities adhere to cGMP standards and have undergone audits by the USFDA and various multinational entities. Furthermore, it provides training and conducts audits for its partners to ensure FDA compliance for their technologies and systems.

Ingredion Incorporated (NYSE: INGR) operates as a global provider of innovative ingredient solutions. In the Pharma and Nutraceuticals sectors, we collaborate with formulators in search of functional materials to improve formulation performance and address technical obstacles. Our Pharma Solutions Portfolio comprises of binders, fillers, superdisintegrants, lubricants, gelatine replacers for softgel, viscosifiers, encapsulation emulsions, and parenteral APIs. Aligned with current and emerging trends and regulations, we are continuously evolving to integrate cGMP facilities, regulatory support, global presence, and collaborative technical assistance to serve as Your Problem-Solving Partner.

As a developer, producer and provider of essential raw materials, we grasp the difficulties faced by our partners and adherence to regulatory demands. We support our associates throughout the journey from the developmental phase to the commercial manufacturing. Our range of services & goods is tailored to our clients' requirements, offering a modular selection and combination: C-Made: Customized formulation manufacturing for application in upstream, downstream and formulation. PharmProve®: Multi-compendial production chemicals for use as an ingredient, excipient or API.

Production, marketing, contract production, and wholesale distribution of primary ingredients, specifically sugar-derived polyols utilized in functional food, pharmaceutical, and chemical applications. Established through a collaboration between Mitsui & Co., Ltd. and Nikken Chemicals Co. Ltd. with the aim of producing sugar-based polyol products (initial capital: 100 million yen). Commenced operations at Nagoya Plant in Chita City, Aichi, and initiated the production of sorbitol and ESWEE, a hydrogenated starch hydrolysate.

Established in 1952, San Fu Group commenced its operations in Banqiao, engaging in the production of food-additive chemicals utilizing internally developed manufacturing technology. Through unwavering dedication for over five decades, we have evolved from a small-scale facility to a global conglomerate generating annual revenue exceeding NT$20 billion. Headquartered in Taiwan, San Fu embodies a dynamic network of numerous subsidiaries and partners across Europe, America, South East Asia, China, and Hong Kong. Additionally, we are fully equipped to deliver a diverse range of products to our clientele, particularly high-tech specialty chemicals, beverages, and food, among others.